MRFR Offers a Thorough Analysis of Throat Cancer Market provides the latest information on the present and the future industry trends, allowing the readers to identify the products and services, hence driving the revenue growth and profitability. Throat Cancer Market Information, by Types (Pharyngeal Cancer and Laryngeal Cancer), by Treatments (Surgery, Radiation Therapy, Chemotherapy, Others) – Forecast to 2022
Global Throat Cancer Market – Competitive Analysis
Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, Eli Lilly And Company, Engeneic Ltd, F. Hoffmann-la Roche AG, Merck & Co., Inc., Novartis, Pfizer Inc., Teva Pharmaceutical Industries Ltd and others are some of the prominent players at the forefront of competition in the global throat cancer market and are profiled in MRFR Analysis.
Global Throat Cancer Market – Overview
Cancer is a condition with uncontrolled division of cells spreading unusually in the body. These abnormal cells accumulate at a specific site to form mass of cells called tumors. Throat cancer refers to tumor of the voice box, the vocal cords, and different parts of the throat, for example, the tonsils and the oropharynx. The throat cancer is categorized into two types: pharyngeal cancer and laryngeal cancer.
The throat cancer market is growing at a fast pace and is expected to growth in the near future. The major factors that driving the growth of this market are the increasing geriatric population, increasing rate of cancer survival, changing lifestyle, high number of tobacco consumers, and increasing smoking population. The treatment procedure for the throat cancer is becoming more effective with increasing success rates. The increasing demand for these treatments will grow resulting in the growth of the global throat cancer market.
Fill Out Details To Receive FREE Sample Here: https://www.marketresearchfuture.com/sample_request/1792
There are emerging new drugs, therapies for the treatment and occurrence of throat cancer, the ever increasing demand and popularity of these treatments will grow eventually. Globally around 157,000 new cases of laryngeal cancer were diagnosed in 2012. According to National Cancer Institute (NIH), about 1.1% of adult population is estimated to be diagnosed with pharyngeal cancer followed by 0.4% with laryngeal cancers at some point during their lifetime.
With the increasing prevalence of throat cancer, raise in HPV infections, alcohol consumption and rising aging population are the major factors driving the growth of throat cancer market in the forecast period. According to American Cancer Society (ACS), around 13,430 new cases of laryngeal cancer were diagnosed among them 79% were men and 21% were women in 2016. Throat cancer are more common in men than women that are probably because of their smoking habits.
Combination therapy are more preferred for the treatment of throat cancer die to different mechanisms and the combined ability to decrease the resistance of the cancer cells to drugs. Cisplatin and 5-FU are more commonly used chemotherapy drugs to treat the throat cancers but these drugs have numerous side effects such as diarrhoea, kidney damage and heart problems. The global throat cancer market has been examined as a swiftly growing market and expected to grow at a tremendous rate.
Ongoing research to develop the newer chemotherapies such as targeted therapies by using EGFR inhibitors and angiogenesis inhibitors to treat the throat cancer. The recent use of transoral robotic surgeries are gaining traction for the physicians to remove the tumors due to minimal invasion to conduct the surgery in a precise manner with fewer side effects. In the case of the radiation therapy, few doctors are trying to kill the cancer cells by using proton beam therapy because these cause less damage to the tissues they pass through than the X-rays.
However, lack of target specific drugs to treat the throat cancer, side effects of the chemotherapy drugs and lack of diagnosis of the disease are some of the factors that may hamper the growth of throat cancer treatment market in near future.
Global Throat Cancer Market – Regional:
Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.
The North America dominated the global throat cancer market with the U.S. holding the largest market share. The factors that drive the throat cancer market are the rising aging population, growing demand for advanced cancer therapies, increasing government funding in the healthcare sector, and growth of cancer care facilities in emerging countries
In Europe, due to increase in the incidence of throat cancer because of increase in smoking, tobacco and alcohol consumption in these regions. Cancer of the larynx is uncommon in the UK with around 2,000 cases developing each year. It is four times more common in men than in women. It is rare in people aged under 40 years and is most common in people aged over 60 years.
Asia Pacific region is expected to grow rapidly with developing countries such as China and India leading this market due to the fast growing healthcare sector and large unmet needs over the forecast period.
The Middle East & African market especially, the African region is expected to witness a poor growth owing to the lack of knowledge in medical sector, and less development in medical facilities in Middle East & Africa will have limited growth in the market.
Table Of Content : Throat Cancer Market
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
5 Global Throat Cancer Market, By Types
5.1.1 Pharyngeal Cancer
5.1.2 Laryngeal Cancer
6 Global Throat Cancer Market, By Treatments
6.1.2 Radiation Therapy
7 Global Throat Cancer Market, By Regions
7.1.1 North America
22.214.171.124 Rest Of Europe
7.1.3 Asia Pacific
126.96.36.199 South Korea
188.8.131.52 Rest Of Asia Pacific
7.1.4 Middle East & Africa
8 Company Landscape
8.1.1 Mergers Acquisitions
8.1.3 Release/New Product Launches
9 Company Profile
9.1 Merck &Co.Inc.
9.1.1 Company Overview
9.1.2 Product/Business Segment Overview
9.1.4 Key Developments
9.2 Bristol-Myers Squibb
9.2.2 Product/Business Segment Overview
9.2.4 Key Developments
9.3 Pfizer Inc.
9.3.2 Product/Business Segment Overview
9.3.4 Key Developments
9.4 Eli Lilly And Company
9.4.2 Product/Business Segment Overview
9.4.4 Key Developments
9.5 F. Hoffmann-La Roche AG
9.5.2 Product/Business Segment Overview
9.5.4 Key Developments
BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 40+ RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/throat-cancer-market-1792
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312